The short-term effects of intranasal steroids on intraocular pressure in pediatric population

Taylan Ozturk1, Ceren Durmaz Engin2, Seher Koksaldi3

  • 1Department of Ophthalmology, Dokuz Eylul University School of Medicine, Izmir, Turkey. ataylan6@yahoo.com.

Insights

Intranasal mometasone furoate (INMF) may cause short-term intraocular pressure (IOP) increases in children with allergic rhinitis (AR). Ophthalmologic evaluation is recommended for children using intranasal steroids due to potential risks.

Area of Science:

  • Ophthalmology
  • Pediatrics
  • Allergy & Immunology

Background:

  • Allergic rhinitis (AR) is common in children.
  • Intranasal steroids are a common treatment for AR.
  • Potential ocular side effects of intranasal steroids, particularly in children, warrant investigation.

Purpose of the Study:

  • To assess the short-term impact of intranasal mometasone furoate (INMF) on intraocular pressure (IOP) in pediatric patients diagnosed with allergic rhinitis (AR).

Main Methods:

  • A cohort of children with AR prescribed INMF nasal spray was enrolled.
  • Ophthalmologic examinations, including Tonopen XL IOP measurements, were conducted pre-treatment and at 1 and 6 weeks post-treatment.
  • Exclusion criteria included ocular diseases other than refractive errors; statistical analysis was performed on demographic and ophthalmologic data.

Main Results:

  • The study included 62 children (mean age 8.55 years).
  • A statistically significant increase in IOP was observed at 1 and 6 weeks post-INMF initiation (p < 0.001).
  • Elevated IOP was noted in children with a positive family history of glaucoma and those with optic disc cupping at the first week.

Conclusions:

  • Children may be more susceptible to steroid-induced ocular hypertensive responses than adults.
  • Ophthalmologic evaluation is advisable for all children undergoing treatment with intranasal steroids.
  • Monitoring IOP is crucial in pediatric patients using INMF for allergic rhinitis.
Abstract

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
538
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
380
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
641
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
462
Epistaxis01:30

Epistaxis

Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
252